Dschietzig, T. B., & Salama, G. (2024). Relaxin-2 for heart failure with preserved ejection fraction: a comment on the termination of a phase-II trial investigating the relaxin-2 analogue, LY3540378. Global Cardiology, 2(4). https://doi.org/10.4081/cardio.2024.56